ACRX - AcelRx Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts6667
Avg. Estimate-0.22-0.2-0.75-0.7
Low Estimate-0.24-0.22-0.79-0.89
High Estimate-0.19-0.19-0.72-0.53
Year Ago EPS-0.21-0.18-0.81-0.75
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts7778
Avg. Estimate960k2.06M4.2M25.76M
Low Estimate470k860k2.53M17.6M
High Estimate1.6M3.32M5.8M38.6M
Year Ago Sales377k613k2.15M4.2M
Sales Growth (year/est)154.60%236.10%95.30%513.30%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.21-0.2-0.22-0.22
EPS Actual-0.21-0.18-0.17-0.16
Difference00.020.050.06
Surprise %0.00%10.00%22.70%27.30%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.22-0.2-0.75-0.7
7 Days Ago-0.22-0.21-0.77-0.7
30 Days Ago-0.23-0.22-0.85-0.66
60 Days Ago-0.23-0.22-0.85-0.66
90 Days Ago-0.23-0.23-0.88-0.66
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days4462
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesACRXIndustrySectorS&P 500
Current Qtr.-4.80%N/AN/A-0.00
Next Qtr.-11.10%N/AN/A0.08
Current Year7.40%N/AN/A0.03
Next Year6.70%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A